Permeation across this protective barrier is actively mediated by the organic cation/carnitine transporter known as OCTN2 (SLC22A5)
However, in the phase II trial, the guadecitabine plus carboplatin group did not show any superior effect compared with the traditional chemotherapy group [239]
Ingredients Sweetener (Glycerine*), Carrier (Aqua), L-Carnitine L-Tartrate, Preservative (Sodium Benzoate), D-Panthenol, Emulsifier (Polysorbate 80), Flavour (Orange (Flavouring Preparations, Dl-alpha tocopherol)) *Vegetable Source
Ask our doctor how PT 141 can benefit you
Cancer Type 3: Tumours in which P53 activity is suppressed at the protein level via dominant MDM2 activity, irrespective of whether suppression is caused by gene amplification or transcriptional upregulation
doi: 10.1002/biof.1829